1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells (1995)
- Authors:
- USP affiliated authors: BRENTANI, MARIA MITZI - FM ; FEDERICO, MIRIAM HATSUE HONDA - FM ; FOLGUEIRA, MARIA APARECIDA AZEVEDO KOIKE - HU
- Unidades: FM; HU
- Assunto: RADIOLOGIA
- Language: Inglês
- Imprenta:
- Publisher: Universidade do Chile
- Publisher place: Santiago
- Date published: 1995
- Source:
- Conference titles: Santiago Southern Summer Symposia
-
ABNT
BRENTANI, Maria Mitzi et al. 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells. 1995, Anais.. Santiago: Universidade do Chile, 1995. . Acesso em: 28 dez. 2025. -
APA
Brentani, M. M., Federico, M. H. H., Folgueira, M. A. A. K., & Escaleira, M. T. F. (1995). 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells. In Molecular Biology of Cell Differentiation and Embryonic Development. Santiago: Universidade do Chile. -
NLM
Brentani MM, Federico MHH, Folgueira MAAK, Escaleira MTF. 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells. Molecular Biology of Cell Differentiation and Embryonic Development. 1995 ;[citado 2025 dez. 28 ] -
Vancouver
Brentani MM, Federico MHH, Folgueira MAAK, Escaleira MTF. 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells. Molecular Biology of Cell Differentiation and Embryonic Development. 1995 ;[citado 2025 dez. 28 ] - Doxorubicin, bleomycin, vincristine (ABV) or etoposide chemotherapy in AIDS: related poor risk Kaposi's sarcoma
- Flow-cytometric dna analysis and hormonal receptor status in brazilian breast cancer patients
- C-ERBB-2 negativo após quimioterapia neoadjuvante (QN) prediz sobrevida livre de doença (SLD) mais longa em pacientes com câncer de mama
- Lowcytometric S-phase fraction, but not ploidy nor hormmonal receptor status predicts survival in brazilian patients with operable breast cancer
- Tumor infiltrating lymphocytes express cd 1 b and beta4 integrin chain
- Flow-cytometric DNA analysis and hormonal receptor status in brazilian breast cancer patients
- Disease free survical in breast cancer with high flowcytometric S phase fraction in Brazilian patients
- Thymocyte subpopulations and clonality in myasthenia gravis
- Carboplatin and etoposide (PE) combined with vincristine (V)-doxorubicin(AD)-cyclophosphamide (C) (VAdc) in ewing´s sarcoma (ES) primitive neuroectodermal tumor (PNET) in adults
- Casing a low c-erb-B2 expression after primary chemotherapy (PCT) predicts longer disease-free survival (DFS) in Brazilian patients with primary breast cancer
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
